Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight

globenewswire.com
ANVS Annovis Bio is mentioned as a key company in the Parkinson's disease market, indicating its involvement in the development of treatments for the condition. The article does not provide specific details on its pipeline or recent performance. SUPN Supernus Pharmaceuticals, Inc. is listed as a key company in the Parkinson's disease market, suggesting its participation in developing treatments for the condition. No specific details about its pipeline or performance are provided. ABBV AbbVie is mentioned as a key company in both the Parkinson's disease market and the Parkinson's disease-related dementia market, indicating its involvement in research and development within these therapeutic areas. VNDA Vanda Pharmaceuticals is mentioned as a key company in both the Parkinson's Disease Psychosis Market and the Psychosis in Parkinson’s and Alzheimer’s Disease Market, indicating its focus on treatments for these conditions. JAZZ Jazz Pharmaceuticals is listed as a key company in the Parkinson's Disease Psychosis Market, suggesting its involvement in developing treatments for this specific aspect of Parkinson's disease. ACAD Acadia Pharmaceuticals Inc. is mentioned as a key company in the Parkinson's Disease Psychosis Market, indicating its focus on treatments related to this condition. MRK Merck Sharp & Dohme is listed as a key company in the Psychosis in Parkinson’s and Alzheimer’s Disease Market, indicating its engagement in research for these complex neurological conditions.

Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight New York, USA, July 16, 2026 (GLOBE NEWSWIRE) -- Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight

The Parkinson's disease clinical trial analysis report delivers important insights into ongoing research of 200+ pipeline Parkinson's disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

DelveInsight’s 'Parkinson's Disease Pipeline Insight 2026' report provides comprehensive global coverage of pipeline therapies for Parkinson's disease across various stages of clinical development. The report offers an in-depth analysis of key trends, emerging therapies, and competitive landscape dynamics, highlighting the strategies of major pharmaceutical companies to advance the pipeline and capitalize on future growth opportunities. In addition, it includes critical insights into clinical trial benchmarking, partnering and licensing activities, and regulatory pathways involving the FDA and EMA, enabling stakeholders to make informed decisions and optimize development strategies within the Parkinson's disease domain.

Parkinson's Disease Clinical Trial Analysis Summary

Request a sample and discover the recent advances in Parkinson's disease drug development @ https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insights

What is Parkinson's Disease?

Parkinson's disease is a progressive neurological condition that primarily affects movement due to the gradual loss of dopamine-producing neurons in a region of the brain called the substantia nigra. This decline in dopamine disrupts normal communication within the brain, leading to hallmark symptoms such as tremors at rest, muscle rigidity, slowed movements, and impaired balance and coordination. In addition to motor symptoms, patients may also experience non-motor issues like depression, sleep disturbances, cognitive changes, and autonomic dysfunction. Although the exact cause is not fully understood, a combination of genetic and environmental factors is believed to contribute. While there is currently no cure, treatments, including medications like Levodopa and surgical interventions, can help manage symptoms and improve quality of life.

Find out more about Parkinson's disease drug development @ Parkinson's Disease Treatment

A snapshot of the Pipeline Parkinson's Disease Drugs mentioned in the report:

Learn more about the emerging Parkinson's disease therapies @ Parkinson's Disease Clinical Trials

As per Stuti Mahajan, consulting manager at DelveInsight, Parkinson’s disease remains a significant unmet medical need, driven by its progressive neurodegenerative nature and increasing prevalence in aging populations. Current therapies primarily provide symptomatic relief, highlighting the need for disease-modifying treatments that can slow or halt disease progression. Advances in biomarkers, gene therapies, and novel neuroprotective approaches are expected to reshape the treatment landscape and improve long-term patient outcomes.

Recent Developments in Parkinson's Disease Treatment Space

Scope of the Parkinson's Disease Pipeline Report

Dive deep into rich insights for new Parkinson's disease treatments, visit @ Parkinson's Disease Drugs

Table of Contents

For further information on the Parkinson's disease cure research, reach out @ Medication for Parkinson's Disease Treatment

Related Reports

Parkinson's Disease Market

Parkinson's Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease companies, including UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma (NeuroDerm), AbbVie, Cerevel Therapeutics, Cerevance, and others.

Cell and Gene Therapy in Parkinson's Disease Market

Cell and Gene Therapy in Parkinson's Disease Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key cell and gene therapy in Parkinson's disease companies including MeiraGTx, Hope Biosciences, Sumitomo Pharma, Prevail Therapeutics, BlueRock Therapeutics, Voyager Therapeutics, and others.

Parkinson's Disease Psychosis Market

Parkinson's Disease Psychosis Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease psychosis companies, including Sumitomo Pharma America Inc., Vanda Pharmaceuticals, Acadia Pharmaceuticals Inc., Otsuka America Pharmaceutical, Lundbeck LLC, Jazz Pharmaceuticals, Alkahest Inc., Sandoz, Sio Gene Therapies, Axovant Sciences Ltd, and others.

Parkinson’s Disease-Related Dementia Market

Parkinson's Disease-Related Dementia Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Parkinson’s disease-related dementia companies, including AbbVie, UCB Biopharma SRL, InnoMedica Schweiz AG, Integrative Research Laboratories AB, H. Lundbeck A/S, Shanghai WD Pharmaceutical Co., Ltd., Cerevance Beta, Inc., and others.

Psychosis in Parkinson’s and Alzheimer’s Disease Market

Psychosis in Parkinson’s and Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psychosis in Parkinson’s and Alzheimer’s disease companies, including Sunovion Pharmaceuticals, Karuna Therapeutics, Vanda Pharmaceuticals, Suven Life Sciences, Enterin, Intra-Cellular Therapies, Merck Sharp & Dohme, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.